Spondyloarthritis & psoriatic arthritis

Comparative Risk of Osteoporosis and Osteoporotic Fractures According to Exposure to 2 Groups of Biologics in Patients With Radiographic Axial Spondyloarthritis

J RheumatolPublished Retrospective cohort study

Authors' conclusion

Exposure to TNFi and IL-17i may be associated with a lower risk of osteoporosis, but not hip fracture, compared with the bDMARD-naïve group. Exposure to TNFi, but not IL-17i, may be associated with a lower risk of vertebral fracture compared with the bDMARD-naïve group.

Study context

Population
Patients with radiographic axial spondyloarthritis (r-axSpA), nationwide; follow-up from r-axSpA diagnosis to December 2021
Participants
37,708 patients
Exposure
Tumor necrosis factor inhibitor (TNFi) vs biologic disease-modifying antirheumatic drug (bDMARD)-naïve, IL-17i vs bDMARD-naïve, and IL-17i vs TNFi
Outcome
Osteoporosis, vertebral fracture and hip fracture, defined by diagnosis codes
Methodological detailsnationwide, multivariable time-varying Cox regression, line of bDMARD treatment matched 4:1 (TNFi vs IL-17i)
  • Nationwide
  • Multivariable time-varying Cox regression
  • Line of bDMARD treatment matched 4:1 (TNFi vs IL-17i)

Main finding

As reported in the abstract

Osteoporosis
Adjusted hazard ratio (95% CI)P value
TNFivs bDMARD-naïve
0.83(0.76–0.90)
P < 0.01
IL-17ivs bDMARD-naïve
0.19(0.10–0.38)
P < 0.01
IL-17ivs TNFiline of bDMARD treatment matched 4:1
0.23(0.11–0.46)
P < 0.01

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)P value
Vertebral fractureTNFivs bDMARD-naïve0.64 (0.59–0.70)P < 0.01
Vertebral fractureIL-17ivs bDMARD-naïveDid not reach statistical significance0.52 (0.25–1.09)P = 0.09

Hip fracture

Hip fracture risk did not differ across groups

Original publication

Comparative Risk of Osteoporosis and Osteoporotic Fractures According to Exposure to 2 Groups of Biologics in Patients With Radiographic Axial Spondyloarthritis. J Rheumatol. Published 1 March 2026. doi:10.3899/jrheum.2025-0988

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.